KSM Feed

Our new study on Coronavirus reinfection.

KSM is publishing a new real world data study on reinfected Maccabi members.

A retrospective analysis of serological data in 116 Israeli healthcare workers administered with the Coronavirus vaccine.

Continuing to monitor vaccinated members. Coronavirus update February 10.

Continuing to monitor vaccinated members at Maccabi.

New analysis 28 days after the first vaccination dose.

KSM publishes world’s first scientific article on effectiveness of Coronavirus vaccine 13-24 days after 1st dose: real world evidence.

KSM – Maccabi Research and Innovation Center – publishes insights from real-time monitoring of Corona virus vaccination data.

COVID-19 Research: KSM has found that diagnosed depression and obesity increases the risk of coronavirus complications among the young population.

World’s first AI-solution for primary diagnosis of breast cancer deployed by IBEX and KSM.

Illnesses Prediction and Home Hospitalization: Vision of the Head of KSM, Dr. Tal Patalon.

KSM’s Research Claims: Children are Significant Carriers of Covid-19.